# Shuwen Biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shuwen-biotech-co

- Industry: Biotechnology
- Headquarters: Huzhou, China
- Website: www.shuwendx.cn
- Total disclosed funding: $29M
- Latest round: Series C (Jul 9, 2025)
- Investors on record: 7

## About

Founded in 2010 ans based in Huzhou, China, Shuwen Biotech Co., Ltd is a high-tech enterprise in the field of in vitro diagnostics, focusing on the research and development and transformation of innovative diagnostic technologies in the field of women's health. In July 2025, Shuwen Biotech Co., Ltd raised approximately CNY 100 million in series C1 funding led by new investor Jin Venture Investment, with participation from returning investor YuanBio Venture. The company provides medical diagnostic reagents, third-party medical testing services, and new drug companion diagnostics. It developed more than the first kind of 20 diagnostic products and services, and formed a series of products centered on the four major areas of tumor, including maternal and infant medicine, critical illness and public health prevention and screening. It also sells diagnostic kits and services. Shuwen Biotech Co., Ltd generates revenue by providing medical test products and related services. The company will use the series C1 funding to accelerate its domestic and international market promotion of diagnostic products, invest in new product research and development, so as to enrich and improve its pipeline of precision diagnosis and treatment products for women's health.

## Funding rounds

- Series C, Jul 9, 2025, $14M — YuanBio Venture, Jin Venture Investment
- Series B, Sep 8, 2021, $16M — Wuxi Guolian Industrial Investment Private Equity Fund Management, Shuncheng Equity Investment Fund, Anyuan Fund
- Series A, Jul 27, 2017 — Qianhai Ark Capital
- Angel, Apr 29, 2016 — YuanBio Venture, Shanghai Zhonghao Asset Management

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Angel, Series C
- Shanghai Zhonghao Asset Management (https://capitalatlas.ai/funds/shanghai-zhonghao-asset-management) — Angel
- Qianhai Ark Capital (https://capitalatlas.ai/funds/qianhai-ark-capital) — Series A
- Wuxi Guolian Industrial Investment Private Equity Fund Management — Series B
- Shuncheng Equity Investment Fund (https://capitalatlas.ai/funds/shuncheng-equity-investment-fund) — Series B
- Anyuan Fund (https://capitalatlas.ai/funds/anyuan-fund) — Series B
- Jin Venture Investment (https://capitalatlas.ai/funds/jin-venture-investment) — Series C